Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Aug 8;136(6):546-548.
doi: 10.1161/CIRCULATIONAHA.117.029340.

When Lightning Strikes: Fulminant Myocarditis in the Realm of Inflammatory Cardiomyopathies

Affiliations
Editorial

When Lightning Strikes: Fulminant Myocarditis in the Realm of Inflammatory Cardiomyopathies

Leslie T Cooper Jr. Circulation. .

Erratum in

No abstract available

Keywords: Editorials; heart failure; myocarditis.

PubMed Disclaimer

Comment on

References

    1. Cooper LT., Jr Myocarditis. N Engl J Med. 2009;360:1526–1538. doi: 10.1056/NEJMra0800028. - DOI - PMC - PubMed
    1. Saji T, Matsuura H, Hasegawa K, Nishikawa T, Yamamoto E, Ohki H, Yasukochi S, Arakaki Y, Joo K, Nakazawa M. Comparison of the clinical presentation, treatment, and outcome of fulminant and acute myocarditis in children. Circ J. 2012;76:1222–1228. - PubMed
    1. Davoudi AR, Maleki AR, Beykmohammadi AR, Tayebi A. Fulminant myopericarditis in an immunocompetent adult due to pandemic 2009 (H1N1) influenza A virus infection. Scand J Infect Dis. 2012;44:470–472. doi: 10.3109/00365548.2011.631575. - DOI - PubMed
    1. Arsenovic N, Sheehan L, Clark D, Moreira R. Fatal carbamazepine induced fulminant eosinophilic (hypersensitivity) myocarditis: emphasis on anatomical and histological characteristics, mechanisms and genetics of drug hypersensitivity and differential diagnosis. J Forensic Leg Med. 2010;17:57–61. doi: 10.1016/j.jflm.2009.07.021. - DOI - PubMed
    1. Thavendiranathan P, Verhaert D, Kendra KL, Raman SV. Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma. Br J Radiol. 2011;84:e99–e102. doi: 10.1259/bjr/13448473. - DOI - PMC - PubMed